Takeda Pharmaceuticals

Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is committed to delivering better health for patients through leading medical innovation. It is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company with a 230-year history. TPUSA currently markets treatments in metabolism, gout, gastrointestinal, and central nervous system therapies. Takeda’s clinical development activities in the U.S. are conducted through Takeda Global Research & Development (TGRD).